Drozd Ksenia V, Manin Alex N, Churakov Andrei V, Perlovich German L
G.A. Krestov Institute of Solution Chemistry of the Russian Academy of Sciences, 1, Akademicheskaya St., 153045 Ivanovo, Russia.
Institute of General and Inorganic Chemistry, RAS, Leninsky Prosp. 31, 119991 Moscow, Russia.
Eur J Pharm Sci. 2017 Mar 1;99:228-239. doi: 10.1016/j.ejps.2016.12.016. Epub 2016 Dec 20.
Experimental multistage cocrystal screening of the antituberculous drug 4-aminosalicylic acid (PASA) has been conducted with a number of coformers (pyrazinamide (PYR), nicotinamide (NAM), isonicotinamide (iNAM), isoniazid (INH), caffeine (CAF) and theophylline (TPH)). The crystal structures of 4-aminosalicylic acid cocrystals with isonicotinamide ([PASA+iNAM] (2:1)) and methanol solvate with caffeine ([PASA+CAF+MeOH] (1:1:1)) have been determined by single X-ray diffraction experiments. For the first time for PASA cocrystals it has been found that the structural unit of the [PASA+iNAM] cocrystal (2:1) is formed by 2 types of heterosynthons: acid-pyridine and acid-amide. The desolvation study of the [PASA+CAF+MeOH] cocrystal solvate (1:1:1) has been conducted. The correlation models linking the melting points of the cocrystals with the melting points of the coformers used in this paper have been developed. The thermochemical and solubility properties for all the obtained cocrystals have been studied. Cocrystallization has been shown to lead not only to PASA solubility improving but also to its higher stability against the chemical decomposition.
已使用多种共晶形成物(吡嗪酰胺(PYR)、烟酰胺(NAM)、异烟酰胺(iNAM)、异烟肼(INH)、咖啡因(CAF)和茶碱(TPH))对抗结核药物4-氨基水杨酸(PASA)进行了实验性多阶段共晶筛选。通过单晶X射线衍射实验确定了4-氨基水杨酸与异烟酰胺([PASA + iNAM](2:1))的共晶以及与咖啡因的甲醇溶剂化物([PASA + CAF + MeOH](1:1:1))的晶体结构。对于PASA共晶,首次发现[PASA + iNAM]共晶(2:1)的结构单元由两种类型的杂合成子形成:酸 - 吡啶和酸 - 酰胺。已对[PASA + CAF + MeOH]共晶溶剂化物(1:1:1)进行了去溶剂化研究。已建立了将共晶熔点与本文中使用的共晶形成物熔点联系起来的相关模型。已研究了所有获得的共晶的热化学和溶解性性质。已表明共结晶不仅导致PASA溶解度提高,而且使其对化学分解具有更高的稳定性。